Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acid

Infection and Immunity

Volumn 74, Issue 10, 2006, Pages 5703-5712

  Theilacker, Christian ^a   Kaczynski, Zbigniew ^b,c   Kropec, Andrea ^a   Fabretti, Francesca ^a   Sange, Tatjana ^a   Holst, Otto ^b   Huebner, Johannes ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

^c UNIVERSITY OF GDA SK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 POLY(GLYCEROL PHOSPHATE); BACTERIAL POLYSACCHARIDE; BACTERIUM ANTIBODY; BUTANOL; DEXTRO ALANINE; EPITOPE; GLYCEROPHOSPHATE; LIPOTEICHOIC ACID; OPSONIN; PEPTIDOGLYCAN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL STRAIN; CHEMICAL ANALYSIS; CHROMATOGRAPHY; ENTEROCOCCUS FAECALIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HYDROLYSIS; IMMUNIZATION; LIPID ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; BACTERIAL CAPSULES; CARBOHYDRATE SEQUENCE; ENTEROCOCCUS FAECALIS; IMMUNE SERA; IMMUNODOMINANT EPITOPES; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; OPSONIN PROTEINS; POLYSACCHARIDES, BACTERIAL; RABBITS; TEICHOIC ACIDS;

EID: 33749266224     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00570-06     Document Type: Article

References (36)

1. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
2. Cieslewicz, M. J., D. L. Kasper, Y. Wang, and M. R. Wessels. 2001. Functional analysis in type 1a group B Streptococcus of a cluster of genes involved in extracellular polysaccharide production by diverse species of streptococci. J. Biol. Chem. 276:139-146.
3. Doran, K. S., E. J. Engelson, A. Khosravi, H. C. Maisey, I. Fedtke, O. Equils, K. S. Michelsen, M. Arditi, A. Peschel, and V. Nizet. 2005. Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J. Clin. Investig. 115:2499-2507.
4. Dubios, M., K. A. Gilles, J. K. Hamilton, P. A. Reabers, and F. Smith. 1956. Colorimetric method for the determination of sugars and related substances. Anal. Chem. 28:350-356.
5. European Antimicrobial Resistance Surveillance System. 2004. EARSS annual report 2004. [Online.] http://www.rivm.nl/earss/result/Monitoring_reports/.
6. Fabretti, F., C. Theilacker, L. Baldessarri, Z. Kaczynski, A. Kropec, O. Holst, and J. Huebner. 2006. Alaninie esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides. Infect. Immun. 74:4164-4171.
7. Fattom, A., S. Shepherd, and W. Karakawa. 1992. Capsular polysaccharide serotyping scheme for Staphylococcus epidermidis. J. Clin. Microbiol. 30:3270-3273.
8. Gerwig, G. J., J. P. Kamerling, and J. F. Vliegenthart. 1979. Determination of the absolute configuration of mono-saccharides in complex carbohydrates by capillary G.L.C. Carbohydr. Res. 77:10-17.
9. Gross, M., S. E. Cramton, F. Gotz, and A. Peschel. 2001. Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces. Infect. Immun. 69:3423-3426.
10. Hancock, L. E., and M. S. Gilmore. 2002. The capsular polysaccharide of Enterococcus faecalis and its relationship to other polysaccharides in the cell wall. Proc. Natl. Acad. Sci. USA 99:1574-1579.
11. Haseley, S. R., O. Holst, and H. Brade. 1997. Structural and serological characterisation of the O-antigenic polysaccharide of the lipopolysaccharide from Acinetobacter haemolyticus strain ATCC 17906. Eur. J. Biochem. 244:761-766.
12. Henneke, P., S. Morath, S. Uematsu, S. Weichert, M. Pfitzenmaier, O. Takeuchi, A. Muller, C. Poyart, S. Akira, R. Berner, G. Teti, A. Geyer, T. Hartung, P. Trieu-Cuot, D. L. Kasper, and D. T. Golenbock. 2005. Role of lipoteichoic acid in the phagocyte response to group B Streptococcus. J. Immunol. 174:6449-6455.
13. Huebner, J., A. Quaas, W. A. Krueger, D. A. Goldmann, and G. B. Pier. 2000. Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci. Infect. Immun. 68:4631-4636.
14. Huebner, J., Y. Wang, W. A. Krueger, L. C. Madoff, G. Martirosian, S. Boisot, D. A. Goldmann, D. L. Kasper, A. O. Tzianabos, and G. B. Pier. 1999. Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infect. Immun. 67:1213-1219.
15. Hufnagel, M., L. E. Hancock, S. Koch, C. Theilacker, M. S. Gilmore, and J. Huebner. 2004. Serological and genetic diversity of capsular polysaccharides in Enterococcus faecalis. J. Clin. Microbiol. 42:2548-2557.
16. Kaczynski, Z., G. Karaperyan, A. Evidente, N. S. Iacobellis, and O. Holst. 2006. The structure of a putative exopolysaccharide of Burkholderia gladioli pv. agaricicola. Carbohydr Res. 341:285-288.
17. Kessler, R. E., and G. D. Shockman. 1979. Enzymatic deacylation of lipoteichoic acid by protoplasts of Streptococcus faecium (Streptococcus faecalis ATCC 9790). J. Bacteriol. 137:1176-1179.
18. Kessler, R. E., I. van de Rijn, and M. McCarty. 1979. Characterization and localization of the enzymatic deacylation of lipoteichoic acid in group A streptococci. J Exp. Med. 150:1498-1509.
19. Laferriere, C. A., R. K. Sood, J. M. de Muys, F. Michon, and H. J. Jennings. 1998. Streptococcus pneumoniae type 14 polysaccharide-conjugate vaccines: length stabilization of opsonophagocytic conformational polysaccharide epitopes. Infect. Immun. 66:2441-2446.
20. Lowry, O. H., N. R. Roberts, K. Y. Leiner, M. L. Wu, and L. Farr. 1954. The quantative histochemistry of the brain. I. Chemical methods. J. Biol. Chem. 207:1-17.
21. Maira-Litran, T., A. Kropec, D. A. Goldmann, and G. B. Pier. 2005. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated staphylococcal poly-N-acetyl-beta- (1-6)-glucosamine. Infect. Immun. 73:6752-6762.
22. McDaniel, L. S., W. D. Waltman II, B. Gray, and D. E. Briles. 1987. A protective monoclonal antibody that reacts with a novel antigen of pneumococcal teichoic acid. Microb. Pathog. 3:249-260.
23. Morath, S., A. Geyer, and T. Hartung. 2001. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 193:393-397.
24. National Nosocomial Infections Surveillance. 2004. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004. Am. J. Infect. Control 32:470-485.
25. Neuhaus, F. C., and J. Baddiley. 2003. A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria. Microbiol. Mol. Biol. Rev. 67:686-723.
26. Pier, G. B, D. Boyer, M. Preston, F. T. Coleman, N. Llosa, S. Mueschenborn-Koglin, C. Theilacker, H. Goldenberg, J. Uchin, G. P. Priebe, M. Grout, M. Posner, and L. Cavacini. 2004. Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. J. Immunol. 173:5671-5678.
27. Pier, G. B., G. J. Small, and H. B. Warren. 1990. Protection against mucoid Pseudomonas aeruginosa in rodent models of endobronchial infections. Science 249:537-540.
28. Robbins, J. B., R. Schneerson, and S. C. Szu. 1995. Hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J Infect. Dis. 171:1387-1398.
29. Sadovskaya, I., E. Vinogradov, J. Li, and S. Jabbouri. 2004. Structural elucidation of the extracellular and cell-wall teichoic acids of Staphylococcus epidermidis RP62A, a reference biofilm-positive strain. Carbohydr. Res. 339:1467-1473.
30. Takeda, S., G. B. Pier, Y. Kojima, M. Tojo, E. Muller, T. Tosteson, and D. A. Goldmann. 1991. Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin. Circulation 84:2539-2546.
31. Theilacker, C., F. T. Coleman, S. Mueschenborn, N. Llosa, M. Grout, and G. B. Pier. 2003. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine. Infect. Immun. 71:3875-3884.
32. Theilacker, C., W. A. Krueger, A. Kropec, and J. Huebner. 2004. Rationale for the development of immunotherapy regimens against enterococcal infections. Vaccine 22(Suppl. 1):S31-S38.
33. Wang, Y., J. Huebner, A. O. Tzianabos, G. Martirosian, D. L. Kasper, and G. B. Pier. 1999. Structure of an antigenic teichoic acid shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Carbohydr. Res. 316:155-160.
34. Wicken, A. J., and J. Baddiley. 1963. Structure of intracellular teichoic acids from group D streptococci. Biochem. J. 87:54-62.
35. Xu, Y., L. Jiang, B. E. Murray, and G. M. Weinstock. 1997. Enterococcus faecalis antigens in human infections. Infect. Immun. 65:4207-4215.
36. Yokoyama, Y., and Y. Harabuchi. 2002. Decreased serum and pharyngeal antibody levels specific to streptococcal lipoteichoic acid in children with recurrent tonsillitis. Int. J. Pediatr. Otorhinolaryngol. 63:199-207.